OnQ Research Selects Merge eClinical OS® for Electronic Data Capture merge eclinical os, OnQ Research, clinical research organization, cro, electronic data capture, edc Self-run, pay-as-you-go solution provides more control over costs and flexible decision-support

OnQ Research Selects Merge eClinicalOS® for Electronic Data Capture

Self-run, pay-as-you-go solution provides more control over costs and flexible decision-support

Merge Healthcare Incorporated (NASDAQ: MRGE), a leading provider of clinical systems and innovations that seek to transform healthcare, today announced that OnQ Research Pty Ltd, a South African based full-service Clinical Research Organization (CRO), has selected Merge’s eClinicalOS® solution for electronic data capture (EDC) to expand their in-house data management service offering.

“To further ensure the quality of our services and eliminate the need to subcontract data management, we were looking for an easy-to-use yet comprehensive system with a flexible costing model,” said Catherine Lund, Managing Director of OnQ Research.

“At OnQ Research, we believe in offering high quality, flexible contract research options to our clients, and were looking for a partner who does the same,” continued Lund. “We were thrilled to learn that Merge had launched a self-run, pay-as-you-go platform – something yet to be seen anywhere else in the industry. With Merge eClinicalOS, we are able to select only the capabilities needed for a particular study, and keep upfront costs to a minimum.”

“With eClinicalOS’ step-by-step, self-service Configurator, our clients can generate their own quotes and create budget scenarios in real-time,” said Zaher El-Assi, General Manager of Merge eClinical. “Cost-transparency and dynamic study estimates provide OnQ Research the flexibility and decision support tools needed as they continue to grow their business.”

Merge eClinicalOS offers a single, easy-to-use interface for all data capture, processing and reporting functions needed to manage a trial. Clinical trial capabilities can be mixed and matched to build a solid foundation for each trial environment, and clients pay for only the functionality they need, when they need it. Plus, it delivers built-in study templates, libraries and reports to help users create studies quickly and manage them effectively without technical assistance.  The latest advancements include the addition of a mobile alerts and reporting application, which allows users to review study data directly from any mobile web-enabled device. The mobile application is anticipated to be released later this month.

About Merge Healthcare
Merge is a leading provider of clinical systems and innovations that seek to transform healthcare.  Merge’s enterprise and cloud-based solutions for image intensive specialties provide access to any image, anywhere, any time. Merge also provides health stations, clinical trials software and other health data and analytics solutions that engage consumers in their personal health. With solutions that are used by providers and consumers and include more than 20 years of innovation, Merge is helping to reduce costs and improve the quality of healthcare worldwide. For more information, visit

About OnQ Research Pty Ltd
Founded in 1999 in Johannesburg, South Africa, OnQ is a niche provider of expert clinical research services, and has the capacity to undertake and facilitate an entire clinical trial in South Africa. OnQ has the ability to provide resource, and appropriate sites throughout Africa. OnQ has been involved in over 120 clinical trials, with a client database well in excess of thirty, which include major Pharmaceutical Companies, Biotech Companies, Medical Device Companies, International CROs, Donor/Government Funded Research and Academic Institutions. For more information, visit

Cautionary Notice Regarding Forward-Looking Statements
The matters discussed in this news release may include forward-looking statements, which could involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, such forward-looking statements. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements.

Lesley Weisenbacher
Vice President, Marketing

 Download this press release >>

© 2017 IBM Watson Health. All Rights Reserved. Privacy | Terms | Email Signup | Sitemap